About 84 per cent of Information Technology (IT) employees have Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), revealed ... senior hepatologist Dr. PN Rao and his team from the ...

The drug has been authorised for use in patients with stage one or two polyneuropathy, commonly referred to as hATTR-PN or ATTRv-PN. The disease affects up to 40,000 ... of TTR protein at its source ...

Gum disease, especially in its more advanced form known as periodontitis, is a chronic inflammatory condition caused by ...

Eating a diet high in red and processed meats puts you at greater risk for non-alcoholic fatty liver disease. These foods are ...

Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...

Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care to reduce excess mortality, researchers said.

and hepatic decompensation among patients with chronic liver disease (CLD). Statins, particularly lipophilic statins like atorvastatin and simvastatin, were associated with a substantial decrease ...

Metabolic-associated Fatty Liver Disease (MAFLD) is previously known as Non-alcoholic Fatty Liver Disease (NAFLD). It is characterized by the build-up of excess fat in the liver, often without any ...